Upadacitinib in Adults With Moderate to Severe Atopic Dermatitis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Allergy and Clinical Immunology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Upadacitinib in Adults With Moderate-to-Severe Atopic Dermatitis: 16-Week Results From a Randomized, Placebo-Controlled Trial
J. Allergy Clin. Immunol 2019 Nov 28;[EPub Ahead of Print], E Guttman-Yassky, D Thaçi, AL Pangan, HC Hong, KA Papp, K Reich, LA Beck, MF Mohamed, AA Othman, JK Anderson, Y Gu, HD Teixeira, JI SilverbergFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.